Sarissa Capital Management
Latest statistics and disclosures from Sarissa Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are INVA, NBIX, CYTK, IRWD, AMRN, and represent 92.85% of Sarissa Capital Management's stock portfolio.
- Added to shares of these 3 stocks: LNTH, REGN, Vor Biopharma.
- Started 2 new stock positions in REGN, Vor Biopharma.
- Reduced shares in these 1 stock: VOR.
- Sold out of its position in VOR.
- Sarissa Capital Management was a net buyer of stock by $7.1M.
- Sarissa Capital Management has $180M in assets under management (AUM), dropping by 16.84%.
- Central Index Key (CIK): 0001577524
Tip: Access up to 7 years of quarterly data
Positions held by Sarissa Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 8 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Innoviva (INVA) | 28.5 | $51M | 2.8M | 18.25 |
|
|
| Neurocrine Biosciences (NBIX) | 23.6 | $43M | 303k | 140.38 |
|
|
| Cytokinetics Com New (CYTK) | 17.9 | $32M | 588k | 54.96 |
|
|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 11.6 | $21M | 16M | 1.31 |
|
|
| Amarin Corp Sponsored Adr (AMRN) | 11.3 | $20M | 1.2M | 16.38 |
|
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 5.2 | $9.3M | +88% | 182k | 51.29 |
|
| Regeneron Pharmaceuticals (REGN) | 1.3 | $2.4M | NEW | 4.2k | 562.27 |
|
| Vor Biopharma Com New | 0.7 | $1.2M | NEW | 25k | 48.72 |
|
Past Filings by Sarissa Capital Management
SEC 13F filings are viewable for Sarissa Capital Management going back to 2013
- Sarissa Capital Management 2025 Q3 filed Nov. 14, 2025
- Sarissa Capital Management 2025 Q2 filed Aug. 14, 2025
- Sarissa Capital Management 2025 Q1 filed May 15, 2025
- Sarissa Capital Management 2024 Q4 filed Feb. 14, 2025
- Sarissa Capital Management 2024 Q3 filed Nov. 14, 2024
- Sarissa Capital Management 2024 Q2 filed Aug. 14, 2024
- Sarissa Capital Management 2024 Q1 filed May 15, 2024
- Sarissa Capital Management 2023 Q4 filed Feb. 14, 2024
- Sarissa Capital Management 2023 Q3 filed Nov. 14, 2023
- Sarissa Capital Management 2023 Q2 filed Aug. 14, 2023
- Sarissa Capital Management 2023 Q1 filed May 15, 2023
- Sarissa Capital Management 2022 Q4 filed Feb. 14, 2023
- Sarissa Capital Management 2022 Q3 filed Nov. 14, 2022
- Sarissa Capital Management 2022 Q2 filed Aug. 15, 2022
- Sarissa Capital Management 2022 Q1 filed May 16, 2022
- Sarissa Capital Management 2021 Q4 filed Feb. 14, 2022